OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer
Gynecologic Oncology2025cited by 10position: middledoi
Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies
Gynecologic Oncology2018cited by 95position: middledoi